There is a robust set of data that proves the role TNF-α and IL-1β as key inflammatory factors leading to the development of IDD, and identifying molecules that can inhibit the production of these cytokines could be an effective mode of treatment for IDD. The gene discussed is TNF; the disease is intervertebral disk degenerative disorder.